SI | Jotup

Himax Technologies, Inc. Reports Third Quarter 2023 Financial Results; Provides Fourth Quarter 2023 Guidance

Retrieved on:

Thursday, November 9, 2023

VR, Public expenditure, Digi-Key, Partnership, CPU, CMOS, OLED, AP, AI, WLO, 3D, RGB, Smartphone, LCD, Prevalence, Quarter, TFT, Maintenance, Tablet, IC, Ecosystem, NEVS, Imagination, Traction, Hand, CNN, AMOLED, RSU, GM, Skeleton, HUD, Liquid crystal on silicon, SI, Artificial intelligence of things, TFT LCD, Notebook, Growth, DSO, ADS, Society for Information Display, Television, Electronics, Policy, OPEX, NEV, AR, Arms industry, Pharmaceutical industry, Fine chemical, Video game, Self storage, Mobile phone, Q2, Himax, Tcon, Q3

TAINAN, Taiwan, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, announced its financial results for the third quarter 2023 ended September 30, 2023.

Key Points:

Gross margin came in at 31.4%, a substantial increase from 21.7% of last quarter, and at the upper end of guidance range of 30.5% to 32.0%.
Q3 profit per diluted ADS was 6.4 cents, exceeding the guidance range of 1.5 cents to 6.0 cents.
Large panel driver IC sales accounted for 18.3% of total revenues for this quarter, compared to 19.3% last quarter and a year ago.
In the third quarter, the automotive business remained Himax’s largest revenue contributor, accounting for nearly 45% of total sales.

Quantum Sensors to Play Vital Role in New Definition of SI Units: High-Precision Measurement Revolutionizes Industries - ResearchAndMarkets.com

Retrieved on:

Thursday, November 9, 2023

The report delves into the rapidly expanding quantum sensor market, covering devices such as CSACs and Quantum Clocks, Quantum Magnetic Sensors, Quantum Gravitometers, Quantum LiDAR, Single-Photon Detectors, and more.

Key Points:

The report delves into the rapidly expanding quantum sensor market, covering devices such as CSACs and Quantum Clocks, Quantum Magnetic Sensors, Quantum Gravitometers, Quantum LiDAR, Single-Photon Detectors, and more.
Fundamental Role in SI Units: Quantum sensors play a fundamental role in the new definition of SI units, which are now precisely defined based on fundamental physical constants of nature rather than physical artifacts.
Quantum Internet-of-Things (QIoT): The growth of the Quantum Internet-of-Things (QIoT) has the potential to significantly boost the quantum sensor market.
As quantum sensors continue to evolve, they are expected to have a transformative impact on industries ranging from healthcare to defense, offering unprecedented measurement precision.

ESMA publishes data for quarterly bond liquidity assessment and the systematic internaliser calculations

Retrieved on:

Thursday, November 9, 2023

Markets in Financial Instruments Directive 2014, SI, OTC, RTS, European Securities and Markets Authority, XML, ESMA, Publication, Observation, Medical device, Security (finance), EU

ESMA publishes data for quarterly bond liquidity assessment and the systematic internaliser calculations

Key Points:

ESMA publishes data for quarterly bond liquidity assessment and the systematic internaliser calculations
The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has today published the new quarterly liquidity assessment of bonds, the data for the quarterly systematic internaliser calculations for equity, equity-like instruments, bonds and for other non-equity instruments under MiFID II and MiFIR.
Bonds quarterly liquidity assessment
ESMA has published the latest quarterly liquidity assessment for bonds available for trading on EU trading venues.
ESMA’s liquidity assessment for bonds is based on a quarterly assessment of quantitative liquidity criteria, which includes the daily average trading activity (trades and notional amount) and the percentage of days traded per quarter.
ESMA also publishes two completeness indicators related to bond liquidity data.

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

Retrieved on:

Monday, November 6, 2023

DSM-IV codes, Anatomy, Operating cost, Patent, International, SI, EBITDA, Research, Growth, Webcast, Lender option borrower option, Depreciation, Investment, Video game, Pharmaceutical industry, Cryptocurrency

Worldwide revenue was $34.0 million in the third quarter 2023, a 29% increase from $26.4 million in the corresponding period in 2022.

Key Points:

Worldwide revenue was $34.0 million in the third quarter 2023, a 29% increase from $26.4 million in the corresponding period in 2022.
Gross margin was 79% for the third quarter 2023, as compared to 84% in the corresponding period in 2022.
Operating expenses increased 6% to $38.1 million in the third quarter 2023, as compared to $35.8 million in the corresponding period in 2022.
SI-BONE will host a conference call to discuss the third quarter 2023 financial results after market close on Monday, November 6, 2023 at 4:30 P.M. Eastern Time.

CMS finalizes new billing code for Posterior SI Joint Fusion to be in-office procedure

Retrieved on:

Friday, November 3, 2023

Arthralgia, ASC, Medicare, Abdominal ultrasonography, SI, LinQ, Health, Ambulatory Surgery Center Association, Synovial joint, SIJ, Overalls, Safety, Centers for Medicare & Medicaid Services, Pain management, Patient, Patient safety, CMS, Hospital, MD

TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has finalized its decision to establish payment rates for PainTEQ's new Current Procedural Terminology (CPT®) code for posterior SI joint fusion in the office setting in addition to hospital outpatient departments (HOPDs) and Ambulatory Surgery Centers (ASCs). This change for PainTEQ's LinQ SI Joint Stabilization procedure redefines the landscape of SI joint pain management for Medicare patients.

Key Points:

This change for PainTEQ 's LinQ SI Joint Stabilization procedure redefines the landscape of SI joint pain management for Medicare patients.
"The integration of an in-office billing code for posterior SIJ fusion into Medicare's framework is a testament to the evolving nature of medical technology and patient care.
"The ability to offer in-office treatment for posterior SIJ fusion represents a crucial step in making comprehensive pain management more accessible.
PainTEQ continues its trajectory as a leader in SI Joint pain solutions, with CMS's final decision further solidifying its position in the medical community.

AMD Introduces New AMD Ryzen Threadripper 7000 Series Processors and Ryzen Threadripper PRO 7000 WX-Series Processors for the Ultimate Workstation

Retrieved on:

Thursday, October 19, 2023

HEDT, OEM, HP Inc., HP, SI, AMD, Original equipment manufacturer, Software, Environment, Growth, Dell, Business, Partnership, AI, DIY, Computing, ISV, Dell Precision, DDR5, GM, Dell Technologies, Video game, Autodesk Revit, Ryzen, Lenovo

SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced the much-anticipated AMD Ryzen™ Threadripper™ PRO 7000 WX-Series processors and reintroduced the Threadripper processor lineup to the high-end desktop space with the Ryzen Threadripper 7000 Series processors, setting a new standard for computing performance and innovation in the industry.

Key Points:

– Introduces new Ryzen Threadripper PRO 7000 WX-Series processors, the ultimate workstation platform from OEMs including Dell Technologies, HP, and Lenovo –
– Unveils Ryzen Threadripper 7000 Series processors, the world’s fastest desktop processor, for the world’s fastest desktop platforms for enthusiasts –
SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced the much-anticipated AMD Ryzen™ Threadripper™ PRO 7000 WX-Series processors and reintroduced the Threadripper processor lineup to the high-end desktop space with the Ryzen Threadripper 7000 Series processors, setting a new standard for computing performance and innovation in the industry.
Designed for professionals and businesses that demand top-tier performance, reliability, expandability, and security, these processors provide the unparalleled multi-core performance of “Zen 4” Threadripper 7000 Series processors.
Simultaneously, AMD is also introducing the AMD Ryzen Threadripper 7000 Series processors, returning to the HEDT environment for the first time since 2020.
The AMD Ryzen Threadripper PRO 7000 WX-Series processors expand on the prior generation’s unrivaled performance and superior platform features for the workstation market.

VGI Medical, LLC Announces The Launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System, for Sacroiliac Joint Transfixation, at NASS 2023

Retrieved on:

Wednesday, October 18, 2023

3D, Sacrum, US, US FDA, SI, Rotation, Multimedia, Quality of life, University, VGI, Pain, Patient, Ilium, University of Toledo, NASS, Medical device, 3D printing

LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System. The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure. The implant has an engineered lattice design to achieve 500-700 mm pores, and has undergone post processing to create micro and nano surface structures facilitating the proliferation of osteoblast adhesion and bony in-growth. The SiJoin® T4 Implant is engineered with a dual geometric shape designed to be simultaneously positioned within the illium and sacrum, through the respective cortical wall, providing high surface area contact for fixation. The implant is held against rotation via the stabilizer fins positioned between the opposing illium and sacrum surfaces, and the non-circular cross-section of the main body. The patented novel design of the SiJoin® T4 Implant fixes the sacrum and ilium relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points:

VGI Medical, LLC announces the launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
VGI's superior engineering and testing has allowed them to design a titanium alloy implant for use in alleviating sacroiliac joint pain and create a simplified process for the surgeon.
LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure.

Captiva Spine Completes WatchTower Spine Navigation System's First ASC 3D Navigated MIS Pedicle Screw Series in the U.S. Using 2D Percutaneous Registration

Retrieved on:

Tuesday, October 17, 2023

JUPITER, Fla., Oct. 17, 2023 /PRNewswire-PRWeb/ -- Captiva Spine®, a medical technology organization connecting healthcare professionals, distribution specialists, and healthcare facilities with cutting-edge spinal care technology, announced the completion of their first Ambulatory Surgery Center (ASC) navigated MIS lumbar fusion series in the U.S. The navigated lumbar spine fusion case series, completed by Dr. Jonathan Hyde of Miami Spine Specialists, was powered by Captiva Spine's state-of-the-art WatchTower™ Spine Navigation System (a U.S. FDA regulatory-cleared system). The WatchTower system's capabilities support an efficient and economical navigation solution for ASCs and community hospitals performing lumbar spine and sacroiliac joint fusion surgery.

Key Points:

The navigated lumbar spine fusion case series, completed by Dr. Jonathan Hyde of Miami Spine Specialists, was powered by Captiva Spine's state-of-the-art WatchTower™ Spine Navigation System.
The navigated lumbar spine fusion case series, completed by Dr. Jonathan Hyde of Miami Spine Specialists, was powered by Captiva Spine's state-of-the-art WatchTower™ Spine Navigation System (a U.S. FDA regulatory-cleared system).
Beyond precision, the WatchTower Spine Navigation System addresses longstanding challenges in navigated spine surgeries: the need for intraoperative CT scanning or open registration.
To schedule a demonstration of the WatchTower Spine Navigation System and our range of spinal and SI fusion options, please visit www.captivaspine.com/spine-navigation .

AMA Introduces New Category I CPT Code 27278 for Posterior SI Joint Fusion

Retrieved on:

Tuesday, October 17, 2023

Patient, American Medical Association, Senior, Sacroiliac joint, Synovial joint, SI, AMA, Arthrodesis, Health, Arthralgia, CPT, LinQ, Physician, Dentistry, Hospital

TAMPA, Fla., Oct. 17, 2023 /PRNewswire/ -- The American Medical Association (AMA) has announced the release of the 2024 CPT code set, which includes a new Category I CPT code for PainTEQ's LinQ SI Joint Stabilization procedure. The new code, effective as of January 1, 2024, is 27278.

Key Points:

TAMPA, Fla., Oct. 17, 2023 /PRNewswire/ -- The American Medical Association (AMA) has announced the release of the 2024 CPT code set, which includes a new Category I CPT code for PainTEQ 's LinQ SI Joint Stabilization procedure.
The detailed description of the new code is:
27278 Arthrodesis, sacroiliac joint, percutaneous, with image guidance, including placement of intra-articular implant(s) (e.g.
Michael Mydra, Senior Vice President, Reimbursement and Market Access at PainTEQ, expressed his enthusiasm about the new code, stating, "The inclusion of the LinQ SI Joint Stabilization procedure as a Category I CPT code is a major milestone for PainTEQ, physicians performing the procedure, and patients suffering from SI Joint pain.
The assignment of this new CPT code is a testament to the efficacy and importance of the LinQ procedure.

SAIL Fusion Announces First Implantations of its BowTie™ Sacroiliac Fusion System

Retrieved on:

Monday, October 16, 2023

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System.

Key Points:

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System.
BowTie is the first SI fusion system to be based on long-standing, proven joint fusion principles established by the AO foundation.
I fully expect these patients to do extremely well.”
Dr. Karimov added, “The BowTie System allowed me to fully access the joint and create an ideal environment for fusion.
We look forward to completing our pilot study and launching the product in the United States in the near future.”